Brought to you by Deciphera Pharmaceuticals Deciphera Pharmaceuticals invites you to join an expert-led discussion: Advancements in the Clinical Management of Advanced Gastrointestinal Stromal Tumor during our Product Theater at the 2021 ONS Annual Congress on April 29, 2021 at 2:00 PM EST. Sandra Brackert, NP-C, will review the first and only switch-control kinase inhibitor for advanced GIST and it’s impact on the […]
Read more
Brought to you by PeerView Institute During the current management era for diffuse large B-cell lymphoma (DLBCL), the emergence and validation of novel antibody-based therapies has offered patients a variety of effective therapeutic options that may be tailored to certain disease characteristics or a specific patient’s therapeutic needs, particularly those who relapse and are not […]
Read more
Brought to you by Pfizer Inc. Please join our speakers, Desiree Grogan, RPA-C, MSHS and patient ambassador Ursula L., on Tuesday, April 20, 2021 at 3:00–3:45 pm EST for an informative promotional product theater sponsored by Pfizer! Desiree Grogan is a Physician Assistant at ProHEALTH Care Associates, LLP in New Hyde Park, NY, specializing in […]
Read more
Danya Garner, MSN, RN, NPD-BC, OCN®, CCRN-KContent Planning Team Member The countdown begins to the start of ONS Congress™ 2021! The entire Content Planning Team is excited to showcase all of the wonderful sessions that we have been planning for you. There will be a plethora of content available to support your continued growth as […]
Read more
Brought to you by Research to Practice Join Dr Neil Love and 29 invited clinical investigators for this unique 11-part NCPD-accredited series designed specifically for oncology nurses. prior to these sessions, Dr Love will be sitting down with nurses in clinical practice from across the country as they present challenging cases from their practices. These recorded conversations will […]
Read more
Brought to you by Takeda Oncology Brain metastases have been reported in up to 35% of TKI treatment-naïve patients. Addressing brain metastases is a major treatment consideration for patients with ALK+ mNSCLC. While ALK inhibitors may extend progression-free survival, quality of life is also important to consider when treating patients with ALK+ mNSCLC. In May […]
Read more
Brought to you by Lilly Oncology For many people living with metastatic breast cancer (MBC), the unique emotional, social, andphysical challenges can take a toll – not just on those with the disease, but also on their familyand friends.Lilly created the More for MBC initiative with the aim of increasing support for the women andmen […]
Read more
Brought to you by MedscapeLIVE! Join MedscapeLIVE! Tuesday, April 20, 2021 for a virtual symposium at ONS. The treatment landscape for multiple myeloma is rapidly evolving. A multitude of new FDA approvals and expanded indications are improving the outlook for patients across all lines of therapy. With new drug classes and novel combinations regularly entering the […]
Read more
Brought to you by International Myeloma Foundation Amy E. Pierre, RN, MSN, ANP-BC In April 2021, the International Myeloma Foundation (IMF) will hold its 14th CE-accredited symposium in conjunction with the virtual ONS Conference. I am honored to be on the faculty for the 2nd time. This IMF symposium will provide the latest information and updates in […]
Read more
April 16, 2021
